View Future GrowthNeurones 過去の業績過去 基準チェック /26Neuronesは、平均年間9.3%の収益成長を遂げていますが、 IT業界の収益は、年間 成長しています。収益は、平均年間8.8% 10.1%収益成長率で 成長しています。 Neuronesの自己資本利益率は13.3%であり、純利益率は6.1%です。主要情報9.31%収益成長率9.24%EPS成長率IT 業界の成長13.19%収益成長率10.06%株主資本利益率13.31%ネット・マージン6.08%前回の決算情報31 Dec 2025最近の業績更新Reported Earnings • Mar 12Full year 2025 earnings releasedFull year 2025 results: Revenue: €857.2m (up 5.8% from FY 2024). Net income: €52.1m (flat on FY 2024). Profit margin: 6.1% (down from 6.5% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the IT industry in France.お知らせ • Nov 05Neurones S.A. to Report Fiscal Year 2025 Results on Mar 11, 2026Neurones S.A. announced that they will report fiscal year 2025 results on Mar 11, 2026分析記事 • Oct 02Neurones (EPA:NRO) Is Posting Promising Earnings But The Good News Doesn’t Stop ThereNeurones S.A.'s ( EPA:NRO ) recent earnings report didn't offer any surprises, with the shares unchanged over the last...Reported Earnings • Sep 12First half 2025 earnings releasedFirst half 2025 results: Revenue: €424.3m (up 5.4% from 1H 2024). Net income: €22.7m (down 7.3% from 1H 2024). Profit margin: 5.3% (down from 6.1% in 1H 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the IT industry in France.Reported Earnings • Mar 09Full year 2024 earnings releasedFull year 2024 results: Revenue: €810.4m (up 9.3% from FY 2023). Net income: €52.5m (up 6.3% from FY 2023). Profit margin: 6.5% (down from 6.7% in FY 2023). The decrease in margin was driven by higher expenses.お知らせ • Sep 19+ 1 more updateNeurones S.A. to Report First Half, 2025 Results on Sep 10, 2025Neurones S.A. announced that they will report first half, 2025 results on Sep 10, 2025すべての更新を表示Recent updatesDeclared Dividend • Apr 29Dividend increased to €1.40Dividend of €1.40 is 7.7% higher than last year. Ex-date: 10th June 2026 Payment date: 12th June 2026 Dividend yield will be 3.9%, which is higher than the industry average of 1.6%. Sustainability & Growth The dividend has increased by an average of 37% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 34% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Apr 28Neurones S.A., Annual General Meeting, Jun 04, 2026Neurones S.A., Annual General Meeting, Jun 04, 2026. Location: 205 avenue georges clemenceau, nanterre FranceBuy Or Sell Opportunity • Mar 20Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 21% to €34.00. The fair value is estimated to be €42.91, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.4% per annum. Earnings are also forecast to grow by 10% per annum over the same time period.Reported Earnings • Mar 12Full year 2025 earnings releasedFull year 2025 results: Revenue: €857.2m (up 5.8% from FY 2024). Net income: €52.1m (flat on FY 2024). Profit margin: 6.1% (down from 6.5% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the IT industry in France.分析記事 • Dec 03These 4 Measures Indicate That Neurones (EPA:NRO) Is Using Debt SafelyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...お知らせ • Nov 08Neurones S.A. Provides Earnings Guidance for the Full Year 2025Neurones S.A. provided earnings guidance for the full year 2025. For the year, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% .分析記事 • Nov 07Estimating The Intrinsic Value Of Neurones S.A. (EPA:NRO)Key Insights The projected fair value for Neurones is €39.18 based on 2 Stage Free Cash Flow to Equity Neurones' €41.15...お知らせ • Nov 05Neurones S.A. to Report Fiscal Year 2025 Results on Mar 11, 2026Neurones S.A. announced that they will report fiscal year 2025 results on Mar 11, 2026分析記事 • Oct 02Neurones (EPA:NRO) Is Posting Promising Earnings But The Good News Doesn’t Stop ThereNeurones S.A.'s ( EPA:NRO ) recent earnings report didn't offer any surprises, with the shares unchanged over the last...Buy Or Sell Opportunity • Sep 26Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to €38.80. The fair value is estimated to be €48.59, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.3% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.Reported Earnings • Sep 12First half 2025 earnings releasedFirst half 2025 results: Revenue: €424.3m (up 5.4% from 1H 2024). Net income: €22.7m (down 7.3% from 1H 2024). Profit margin: 5.3% (down from 6.1% in 1H 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the IT industry in France.分析記事 • Aug 30Returns At Neurones (EPA:NRO) Appear To Be Weighed DownWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...Price Target Changed • Aug 07Price target decreased by 13% to €52.00Down from €60.00, the current price target is provided by 1 analyst. New target price is 25% above last closing price of €41.65. Stock is down 1.5% over the past year. The company is forecast to post earnings per share of €1.99 for next year compared to €2.17 last year.分析記事 • Jun 24Neurones (EPA:NRO) Has A Rock Solid Balance SheetLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Upcoming Dividend • Jun 04Upcoming dividend of €1.30 per shareEligible shareholders must have bought the stock before 11 June 2025. Payment date: 13 June 2025. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of French dividend payers (5.5%). Higher than average of industry peers (2.3%).分析記事 • May 30Neurones S.A.'s (EPA:NRO) CEO Looks Due For A Compensation RaiseKey Insights Neurones will host its Annual General Meeting on 5th of June Total pay for CEO Luc de Chammard includes...Declared Dividend • May 02Dividend increased to €1.30Dividend of €1.30 is 8.3% higher than last year. Ex-date: 11th June 2025 Payment date: 13th June 2025 Dividend yield will be 2.7%, which is higher than the industry average of 1.6%. Sustainability & Growth The dividend has increased by an average of 36% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 11% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Apr 29Neurones S.A., Annual General Meeting, Jun 05, 2025Neurones S.A., Annual General Meeting, Jun 05, 2025. Location: 205 avenue georges clemenceau, nanterre France分析記事 • Apr 04Neurones S.A.'s (EPA:NRO) Shares May Have Run Too Fast Too SoonWhen close to half the companies in France have price-to-earnings ratios (or "P/E's") below 14x, you may consider...Reported Earnings • Mar 09Full year 2024 earnings releasedFull year 2024 results: Revenue: €810.4m (up 9.3% from FY 2023). Net income: €52.5m (up 6.3% from FY 2023). Profit margin: 6.5% (down from 6.7% in FY 2023). The decrease in margin was driven by higher expenses.お知らせ • Mar 06Neurones S.A. Proposes Dividend for 2024Neurones S.A. announced that att the Shareholders' Meeting on June 5, 2025, the Board will suggest paying a dividend of €1.3 per share for 2024 (compared with €1.2 the previous year).Price Target Changed • Feb 13Price target increased by 13% to €54.00Up from €48.00, the current price target is provided by 1 analyst. New target price is 14% above last closing price of €47.40. Stock is up 7.7% over the past year. The company is forecast to post earnings per share of €2.05 for next year compared to €2.04 last year.お知らせ • Sep 19+ 1 more updateNeurones S.A. to Report First Half, 2025 Results on Sep 10, 2025Neurones S.A. announced that they will report first half, 2025 results on Sep 10, 2025Buy Or Sell Opportunity • Aug 03Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 11% to €40.75. The fair value is estimated to be €51.45, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 8.0% in a year. Earnings are forecast to grow by 2.2% in the next year.分析記事 • Jul 27What Neurones S.A.'s (EPA:NRO) P/E Is Not Telling YouWhen close to half the companies in France have price-to-earnings ratios (or "P/E's") below 15x, you may consider...Upcoming Dividend • Jun 05Upcoming dividend of €1.20 per shareEligible shareholders must have bought the stock before 12 June 2024. Payment date: 14 June 2024. Payout ratio is a comfortable 59% and this is well supported by cash flows. Trailing yield: 2.5%. Lower than top quartile of French dividend payers (5.1%). Higher than average of industry peers (1.8%).お知らせ • May 17Neurones S.A. Provides Earnings Guidance for the Year 2024Neurones S.A. provided earnings guidance for the year 2024. For the period, the company forecasts close to €800 million in revenues, operating profit of around 9.5%.Declared Dividend • May 03Dividend of €1.20 announcedShareholders will receive a dividend of €1.20. Ex-date: 12th June 2024 Payment date: 14th June 2024 Dividend yield will be 2.7%, which is higher than the industry average of 1.6%. Sustainability & Growth The dividend has increased by an average of 35% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to remain steady over the next year, which should provide adequate earnings cover for the dividend.分析記事 • Apr 26Returns On Capital At Neurones (EPA:NRO) Have Hit The BrakesTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...Buy Or Sell Opportunity • Apr 11Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 9.7% to €46.95. The fair value is estimated to be €38.99, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year.Reported Earnings • Mar 08Full year 2023 earnings releasedFull year 2023 results: Revenue: €741.2m (up 11% from FY 2022). Net income: €49.4m (up 12% from FY 2022). Profit margin: 6.7% (up from 6.6% in FY 2022). The increase in margin was driven by higher revenue.分析記事 • Dec 01Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For ExcitementIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...お知らせ • Nov 28+ 2 more updatesNeurones S.A. to Report Fiscal Year 2023 Results on Mar 06, 2024Neurones S.A. announced that they will report fiscal year 2023 results on Mar 06, 2024お知らせ • Nov 10Neurones S.A. Provides Earnings Guidance for the Year 2023Neurones S.A. provided earnings guidance for the year 2023. The company confirms its forecasts for 2023 as a whole: revenues of more than €730 million, operating profit of around 10%.Buying Opportunity • Oct 09Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 7.3%. The fair value is estimated to be €46.26, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.Buying Opportunity • Sep 14Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 12%. The fair value is estimated to be €45.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 18%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 20% in the next 2 years.Reported Earnings • Sep 08First half 2023 earnings releasedFirst half 2023 results: Revenue: €368.7m (up 13% from 1H 2022). Net income: €25.4m (up 15% from 1H 2022). Profit margin: 6.9% (up from 6.7% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 6.9% growth forecast for the IT industry in France.お知らせ • Sep 07Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of more than €730 million and operating profit of around 10%.Upcoming Dividend • Jun 07Upcoming dividend of €1.10 per share at 2.8% yieldEligible shareholders must have bought the stock before 14 June 2023. Payment date: 16 June 2023. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of French dividend payers (5.2%). Higher than average of industry peers (1.9%).分析記事 • May 18If EPS Growth Is Important To You, Neurones (EPA:NRO) Presents An OpportunityInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...お知らせ • May 11Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of €730 million and operating profit of around 10%.Reported Earnings • Mar 12Full year 2022 earnings releasedFull year 2022 results: Revenue: €665.4m (up 15% from FY 2021). Net income: €44.3m (up 18% from FY 2021). Profit margin: 6.7% (up from 6.5% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 2 years, compared to a 7.3% growth forecast for the IT industry in France.分析記事 • Feb 10Neurones' (EPA:NRO) Returns Have Hit A WallIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...お知らせ • Feb 09Neurones S.A. to Report Fiscal Year 2022 Results on Mar 08, 2023Neurones S.A. announced that they will report fiscal year 2022 results After-Market on Mar 08, 2023Price Target Changed • Dec 08Price target increased to €44.33Up from €41.00, the current price target is an average from 3 analysts. New target price is 15% above last closing price of €38.50. Stock is up 11% over the past year. The company is forecast to post earnings per share of €1.89 for next year compared to €1.56 last year.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Nov 12Neurones S.A., Annual General Meeting, Jun 08, 2023Neurones S.A., Annual General Meeting, Jun 08, 2023.お知らせ • Nov 11Neurones S.A. to Report First Half, 2023 Results on Sep 06, 2023Neurones S.A. announced that they will report first half, 2023 results on Sep 06, 2023分析記事 • Oct 26Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For ExcitementFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...分析記事 • Sep 22Does Neurones (EPA:NRO) Deserve A Spot On Your Watchlist?The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...お知らせ • Sep 10Neurones S.A. Confirms its Earnings Guidance for the Full Year 2022Neurones S.A. confirmed its earnings guidance for the full year 2022. For the year, the company expects revenues of at least €640 million and an operating profit of around 10.5%.Reported Earnings • Sep 09First half 2022 earnings releasedFirst half 2022 results: Revenue: €327.1m (up 13% from 1H 2021). Net income: €22.1m (up 21% from 1H 2021). Profit margin: 6.8% (up from 6.3% in 1H 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the IT industry in France.お知らせ • Aug 04Neurones S.A. Provides Earnings Guidance for the Year 2022Neurones S.A. provided earnings guidance for the year 2022. The company expects revenues of at least €640 million (vs. €625 million previously forecast), An operating profit of around 10.5% (vs > 10%).Upcoming Dividend • Jun 01Upcoming dividend of €1.00 per shareEligible shareholders must have bought the stock before 08 June 2022. Payment date: 10 June 2022. Trailing yield: 2.8%. Lower than top quartile of French dividend payers (4.9%). Higher than average of industry peers (1.6%).分析記事 • Apr 28Neurones (EPA:NRO) Will Pay A Smaller Dividend Than Last YearNeurones S.A. ( EPA:NRO ) has announced it will be reducing its dividend payable on the 10th of June to €1.00. However...Reported Earnings • Apr 27Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €579.9m (up 11% from FY 2020). Net income: €37.7m (up 22% from FY 2020). Profit margin: 6.5% (up from 5.9% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 8.3%, compared to a 12% growth forecast for the industry in France.Price Target Changed • Apr 27Price target increased to €41.00Up from €37.50, the current price target is an average from 3 analysts. New target price is 17% above last closing price of €35.10. Stock is up 25% over the past year.Board Change • Apr 27Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Mar 11Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €579.9m (up 11% from FY 2020). Net income: €37.7m (up 22% from FY 2020). Profit margin: 6.5% (up from 5.9% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 8.3%, compared to a 11% growth forecast for the industry in France.分析記事 • Jan 25Should You Be Adding Neurones (EPA:NRO) To Your Watchlist Today?Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...分析記事 • Jan 06Returns At Neurones (EPA:NRO) Appear To Be Weighed DownIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...分析記事 • Jul 20Returns On Capital At Neurones (EPA:NRO) Paint A Concerning PictureIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Upcoming Dividend • Jun 02Upcoming dividend of €2.00 per shareEligible shareholders must have bought the stock before 09 June 2021. Payment date: 11 June 2021. Trailing yield: 0.7%. Lower than top quartile of French dividend payers (3.8%). Lower than average of industry peers (1.4%).Price Target Changed • May 12Price target increased to €32.50Up from €30.00, the current price target is an average from 2 analysts. New target price is 18% above last closing price of €27.60. Stock is up 36% over the past year.Price Target Changed • May 06Price target increased to €31.00Up from €28.25, the current price target is an average from 2 analysts. New target price is 8.0% above last closing price of €28.70. Stock is up 47% over the past year.分析記事 • May 06Is Neurones S.A. (EPA:NRO) Trading At A 25% Discount?In this article we are going to estimate the intrinsic value of Neurones S.A. ( EPA:NRO ) by taking the expected future...Reported Earnings • May 02Full year 2020 earnings released: EPS €1.28 (vs €1.27 in FY 2019)The company reported a mediocre full year result with weaker profit margins, although earnings were flat and revenues improved. Full year 2020 results: Revenue: €524.5m (up 2.8% from FY 2019). Net income: €30.9m (flat on FY 2019). Profit margin: 5.9% (down from 6.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 2% per year.分析記事 • Mar 24Some Investors May Be Worried About Neurones' (EPA:NRO) Returns On CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...分析記事 • Mar 09Neurones S.A.'s (EPA:NRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?Most readers would already be aware that Neurones' (EPA:NRO) stock increased significantly by 15% over the past three...Reported Earnings • Mar 06Full year 2020 earnings releasedThe company reported a mediocre full year result with weaker profit margins, although earnings were flat and revenues improved. Full year 2020 results: Revenue: €524.5m (up 2.8% from FY 2019). Net income: €30.9m (flat on FY 2019). Profit margin: 5.9% (down from 6.0% in FY 2019). The decrease in margin was driven by higher expenses.Analyst Estimate Surprise Post Earnings • Mar 06Revenue beats expectationsRevenue exceeded analyst estimates by 1.2%. Over the next year, revenue is forecast to grow 5.0%, compared to a 33% growth forecast for the IT industry in France.分析記事 • Feb 16The Neurones (EPA:NRO) Share Price Has Gained 54% And Shareholders Are Hoping For MoreThese days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But you can do a...Is New 90 Day High Low • Feb 12New 90-day high: €25.70The company is up 9.0% from its price of €23.50 on 13 November 2020. The French market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the IT industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €18.84 per share.Price Target Changed • Feb 12Price target raised to €29.00Up from €27.00, the current price target is an average from 2 analysts. The new target price is 13% above the current share price of €25.70. As of last close, the stock is up 12% over the past year.分析記事 • Jan 25Here's Why Neurones's (EPA:NRO) Statutory Earnings Are Arguably Too ConservativeAs a general rule, we think profitable companies are less risky than companies that lose money. However, sometimes...Price Target Changed • Jan 14Price target raised to €28.25Up from €26.00, the current price target is an average from 2 analysts. The new target price is 21% above the current share price of €23.40. As of last close, the stock is up 14% over the past year.分析記事 • Jan 11What Percentage Of Neurones S.A. (EPA:NRO) Shares Do Insiders Own?If you want to know who really controls Neurones S.A. ( EPA:NRO ), then you'll have to look at the makeup of its share...分析記事 • Dec 28Should Neurones S.A. (EPA:NRO) Be Part Of Your Dividend Portfolio?Today we'll take a closer look at Neurones S.A. ( EPA:NRO ) from a dividend investor's perspective. Owning a strong...Is New 90 Day High Low • Dec 24New 90-day low: €23.00The company is down 3.0% from its price of €23.60 on 24 September 2020. The French market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the IT industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €18.98 per share.分析記事 • Dec 15Are Neurones S.A. (EPA:NRO) Investors Paying Above The Intrinsic Value?Does the December share price for Neurones S.A. ( EPA:NRO ) reflect what it's really worth? Today, we will estimate the...分析記事 • Dec 02What We Learned About Neurones' (EPA:NRO) CEO PayThe CEO of Neurones S.A. ( EPA:NRO ) is Luc de Chammard, and this article examines the executive's compensation against...分析記事 • Nov 17Investors Who Bought Neurones (EPA:NRO) Shares Five Years Ago Are Now Up 39%Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...Major Estimate Revision • Nov 07Analysts increase EPS estimates to €1.12The 2020 consensus revenue estimate increased from €499.7m to €512.6m. The earnings per share estimate also received an upgrade from €1.00 to €1.12 for the same period. Net income is expected to shrink by 1.2% next year compared to 0.8% growth forecast for the IT industry in France . The consensus price target increased from €26.00 to €27.00. Share price is up 2.1% to €23.90 over the past week.お知らせ • Oct 04+ 1 more updateNeurones S.A. to Report Fiscal Year 2020 Results on Mar 03, 2021Neurones S.A. announced that they will report fiscal year 2020 results at 3:40 PM, GMT Standard Time on Mar 03, 2021分析記事 • Jun 30Neurones (EPA:NRO) Is Growing Earnings But Are They A Good Guide?Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...収支内訳Neurones の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史ENXTPA:NRO 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Dec 2585752316030 Sep 2584551309030 Jun 2583251302031 Mar 2582152295031 Dec 2481053287030 Sep 2479351278030 Jun 2477548269031 Mar 2475849259031 Dec 2374149249030 Sep 2372449240030 Jun 2370748232031 Mar 2368646223031 Dec 2266544215030 Sep 2264243204030 Jun 2261841192031 Mar 2259940183031 Dec 2158038175030 Sep 2157037171030 Jun 2155936166031 Mar 2154233160031 Dec 2052431154030 Sep 2051830151030 Jun 2051128149031 Mar 2051030148031 Dec 1951031147030 Sep 1950530147030 Jun 1950130146031 Mar 1949528145031 Dec 1849026143030 Sep 1848726141030 Jun 1848326138031 Mar 1848427136031 Dec 1748527134030 Sep 1747827130030 Jun 1747027126031 Mar 1745926122031 Dec 1644725117030 Sep 1643624114030 Jun 1642523110031 Mar 1641222105031 Dec 153992199030 Sep 153862193030 Jun 1537421860質の高い収益: NROは 高品質の収益 を持っています。利益率の向上: NROの現在の純利益率 (6.1%)は、昨年(6.5%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: NROの収益は過去 5 年間で年間9.3%増加しました。成長の加速: NROは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: NROは過去 1 年間で収益成長率がマイナス ( -0.9% ) となったため、 IT業界平均 ( -4.1% ) と比較することが困難です。株主資本利益率高いROE: NROの 自己資本利益率 ( 13.3% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YSoftware 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/20 13:20終値2026/05/20 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Neurones S.A. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Alexandre PlaudCIC Market Solutions (ESN)
Reported Earnings • Mar 12Full year 2025 earnings releasedFull year 2025 results: Revenue: €857.2m (up 5.8% from FY 2024). Net income: €52.1m (flat on FY 2024). Profit margin: 6.1% (down from 6.5% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the IT industry in France.
お知らせ • Nov 05Neurones S.A. to Report Fiscal Year 2025 Results on Mar 11, 2026Neurones S.A. announced that they will report fiscal year 2025 results on Mar 11, 2026
分析記事 • Oct 02Neurones (EPA:NRO) Is Posting Promising Earnings But The Good News Doesn’t Stop ThereNeurones S.A.'s ( EPA:NRO ) recent earnings report didn't offer any surprises, with the shares unchanged over the last...
Reported Earnings • Sep 12First half 2025 earnings releasedFirst half 2025 results: Revenue: €424.3m (up 5.4% from 1H 2024). Net income: €22.7m (down 7.3% from 1H 2024). Profit margin: 5.3% (down from 6.1% in 1H 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the IT industry in France.
Reported Earnings • Mar 09Full year 2024 earnings releasedFull year 2024 results: Revenue: €810.4m (up 9.3% from FY 2023). Net income: €52.5m (up 6.3% from FY 2023). Profit margin: 6.5% (down from 6.7% in FY 2023). The decrease in margin was driven by higher expenses.
お知らせ • Sep 19+ 1 more updateNeurones S.A. to Report First Half, 2025 Results on Sep 10, 2025Neurones S.A. announced that they will report first half, 2025 results on Sep 10, 2025
Declared Dividend • Apr 29Dividend increased to €1.40Dividend of €1.40 is 7.7% higher than last year. Ex-date: 10th June 2026 Payment date: 12th June 2026 Dividend yield will be 3.9%, which is higher than the industry average of 1.6%. Sustainability & Growth The dividend has increased by an average of 37% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 34% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Apr 28Neurones S.A., Annual General Meeting, Jun 04, 2026Neurones S.A., Annual General Meeting, Jun 04, 2026. Location: 205 avenue georges clemenceau, nanterre France
Buy Or Sell Opportunity • Mar 20Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 21% to €34.00. The fair value is estimated to be €42.91, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.4% per annum. Earnings are also forecast to grow by 10% per annum over the same time period.
Reported Earnings • Mar 12Full year 2025 earnings releasedFull year 2025 results: Revenue: €857.2m (up 5.8% from FY 2024). Net income: €52.1m (flat on FY 2024). Profit margin: 6.1% (down from 6.5% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the IT industry in France.
分析記事 • Dec 03These 4 Measures Indicate That Neurones (EPA:NRO) Is Using Debt SafelyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
お知らせ • Nov 08Neurones S.A. Provides Earnings Guidance for the Full Year 2025Neurones S.A. provided earnings guidance for the full year 2025. For the year, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% .
分析記事 • Nov 07Estimating The Intrinsic Value Of Neurones S.A. (EPA:NRO)Key Insights The projected fair value for Neurones is €39.18 based on 2 Stage Free Cash Flow to Equity Neurones' €41.15...
お知らせ • Nov 05Neurones S.A. to Report Fiscal Year 2025 Results on Mar 11, 2026Neurones S.A. announced that they will report fiscal year 2025 results on Mar 11, 2026
分析記事 • Oct 02Neurones (EPA:NRO) Is Posting Promising Earnings But The Good News Doesn’t Stop ThereNeurones S.A.'s ( EPA:NRO ) recent earnings report didn't offer any surprises, with the shares unchanged over the last...
Buy Or Sell Opportunity • Sep 26Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to €38.80. The fair value is estimated to be €48.59, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.3% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.
Reported Earnings • Sep 12First half 2025 earnings releasedFirst half 2025 results: Revenue: €424.3m (up 5.4% from 1H 2024). Net income: €22.7m (down 7.3% from 1H 2024). Profit margin: 5.3% (down from 6.1% in 1H 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the IT industry in France.
分析記事 • Aug 30Returns At Neurones (EPA:NRO) Appear To Be Weighed DownWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...
Price Target Changed • Aug 07Price target decreased by 13% to €52.00Down from €60.00, the current price target is provided by 1 analyst. New target price is 25% above last closing price of €41.65. Stock is down 1.5% over the past year. The company is forecast to post earnings per share of €1.99 for next year compared to €2.17 last year.
分析記事 • Jun 24Neurones (EPA:NRO) Has A Rock Solid Balance SheetLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Upcoming Dividend • Jun 04Upcoming dividend of €1.30 per shareEligible shareholders must have bought the stock before 11 June 2025. Payment date: 13 June 2025. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of French dividend payers (5.5%). Higher than average of industry peers (2.3%).
分析記事 • May 30Neurones S.A.'s (EPA:NRO) CEO Looks Due For A Compensation RaiseKey Insights Neurones will host its Annual General Meeting on 5th of June Total pay for CEO Luc de Chammard includes...
Declared Dividend • May 02Dividend increased to €1.30Dividend of €1.30 is 8.3% higher than last year. Ex-date: 11th June 2025 Payment date: 13th June 2025 Dividend yield will be 2.7%, which is higher than the industry average of 1.6%. Sustainability & Growth The dividend has increased by an average of 36% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 11% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Apr 29Neurones S.A., Annual General Meeting, Jun 05, 2025Neurones S.A., Annual General Meeting, Jun 05, 2025. Location: 205 avenue georges clemenceau, nanterre France
分析記事 • Apr 04Neurones S.A.'s (EPA:NRO) Shares May Have Run Too Fast Too SoonWhen close to half the companies in France have price-to-earnings ratios (or "P/E's") below 14x, you may consider...
Reported Earnings • Mar 09Full year 2024 earnings releasedFull year 2024 results: Revenue: €810.4m (up 9.3% from FY 2023). Net income: €52.5m (up 6.3% from FY 2023). Profit margin: 6.5% (down from 6.7% in FY 2023). The decrease in margin was driven by higher expenses.
お知らせ • Mar 06Neurones S.A. Proposes Dividend for 2024Neurones S.A. announced that att the Shareholders' Meeting on June 5, 2025, the Board will suggest paying a dividend of €1.3 per share for 2024 (compared with €1.2 the previous year).
Price Target Changed • Feb 13Price target increased by 13% to €54.00Up from €48.00, the current price target is provided by 1 analyst. New target price is 14% above last closing price of €47.40. Stock is up 7.7% over the past year. The company is forecast to post earnings per share of €2.05 for next year compared to €2.04 last year.
お知らせ • Sep 19+ 1 more updateNeurones S.A. to Report First Half, 2025 Results on Sep 10, 2025Neurones S.A. announced that they will report first half, 2025 results on Sep 10, 2025
Buy Or Sell Opportunity • Aug 03Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 11% to €40.75. The fair value is estimated to be €51.45, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 8.0% in a year. Earnings are forecast to grow by 2.2% in the next year.
分析記事 • Jul 27What Neurones S.A.'s (EPA:NRO) P/E Is Not Telling YouWhen close to half the companies in France have price-to-earnings ratios (or "P/E's") below 15x, you may consider...
Upcoming Dividend • Jun 05Upcoming dividend of €1.20 per shareEligible shareholders must have bought the stock before 12 June 2024. Payment date: 14 June 2024. Payout ratio is a comfortable 59% and this is well supported by cash flows. Trailing yield: 2.5%. Lower than top quartile of French dividend payers (5.1%). Higher than average of industry peers (1.8%).
お知らせ • May 17Neurones S.A. Provides Earnings Guidance for the Year 2024Neurones S.A. provided earnings guidance for the year 2024. For the period, the company forecasts close to €800 million in revenues, operating profit of around 9.5%.
Declared Dividend • May 03Dividend of €1.20 announcedShareholders will receive a dividend of €1.20. Ex-date: 12th June 2024 Payment date: 14th June 2024 Dividend yield will be 2.7%, which is higher than the industry average of 1.6%. Sustainability & Growth The dividend has increased by an average of 35% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to remain steady over the next year, which should provide adequate earnings cover for the dividend.
分析記事 • Apr 26Returns On Capital At Neurones (EPA:NRO) Have Hit The BrakesTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
Buy Or Sell Opportunity • Apr 11Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 9.7% to €46.95. The fair value is estimated to be €38.99, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year.
Reported Earnings • Mar 08Full year 2023 earnings releasedFull year 2023 results: Revenue: €741.2m (up 11% from FY 2022). Net income: €49.4m (up 12% from FY 2022). Profit margin: 6.7% (up from 6.6% in FY 2022). The increase in margin was driven by higher revenue.
分析記事 • Dec 01Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For ExcitementIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
お知らせ • Nov 28+ 2 more updatesNeurones S.A. to Report Fiscal Year 2023 Results on Mar 06, 2024Neurones S.A. announced that they will report fiscal year 2023 results on Mar 06, 2024
お知らせ • Nov 10Neurones S.A. Provides Earnings Guidance for the Year 2023Neurones S.A. provided earnings guidance for the year 2023. The company confirms its forecasts for 2023 as a whole: revenues of more than €730 million, operating profit of around 10%.
Buying Opportunity • Oct 09Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 7.3%. The fair value is estimated to be €46.26, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.
Buying Opportunity • Sep 14Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 12%. The fair value is estimated to be €45.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 18%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 20% in the next 2 years.
Reported Earnings • Sep 08First half 2023 earnings releasedFirst half 2023 results: Revenue: €368.7m (up 13% from 1H 2022). Net income: €25.4m (up 15% from 1H 2022). Profit margin: 6.9% (up from 6.7% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 6.9% growth forecast for the IT industry in France.
お知らせ • Sep 07Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of more than €730 million and operating profit of around 10%.
Upcoming Dividend • Jun 07Upcoming dividend of €1.10 per share at 2.8% yieldEligible shareholders must have bought the stock before 14 June 2023. Payment date: 16 June 2023. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of French dividend payers (5.2%). Higher than average of industry peers (1.9%).
分析記事 • May 18If EPS Growth Is Important To You, Neurones (EPA:NRO) Presents An OpportunityInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
お知らせ • May 11Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of €730 million and operating profit of around 10%.
Reported Earnings • Mar 12Full year 2022 earnings releasedFull year 2022 results: Revenue: €665.4m (up 15% from FY 2021). Net income: €44.3m (up 18% from FY 2021). Profit margin: 6.7% (up from 6.5% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 2 years, compared to a 7.3% growth forecast for the IT industry in France.
分析記事 • Feb 10Neurones' (EPA:NRO) Returns Have Hit A WallIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...
お知らせ • Feb 09Neurones S.A. to Report Fiscal Year 2022 Results on Mar 08, 2023Neurones S.A. announced that they will report fiscal year 2022 results After-Market on Mar 08, 2023
Price Target Changed • Dec 08Price target increased to €44.33Up from €41.00, the current price target is an average from 3 analysts. New target price is 15% above last closing price of €38.50. Stock is up 11% over the past year. The company is forecast to post earnings per share of €1.89 for next year compared to €1.56 last year.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Nov 12Neurones S.A., Annual General Meeting, Jun 08, 2023Neurones S.A., Annual General Meeting, Jun 08, 2023.
お知らせ • Nov 11Neurones S.A. to Report First Half, 2023 Results on Sep 06, 2023Neurones S.A. announced that they will report first half, 2023 results on Sep 06, 2023
分析記事 • Oct 26Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For ExcitementFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
分析記事 • Sep 22Does Neurones (EPA:NRO) Deserve A Spot On Your Watchlist?The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
お知らせ • Sep 10Neurones S.A. Confirms its Earnings Guidance for the Full Year 2022Neurones S.A. confirmed its earnings guidance for the full year 2022. For the year, the company expects revenues of at least €640 million and an operating profit of around 10.5%.
Reported Earnings • Sep 09First half 2022 earnings releasedFirst half 2022 results: Revenue: €327.1m (up 13% from 1H 2021). Net income: €22.1m (up 21% from 1H 2021). Profit margin: 6.8% (up from 6.3% in 1H 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the IT industry in France.
お知らせ • Aug 04Neurones S.A. Provides Earnings Guidance for the Year 2022Neurones S.A. provided earnings guidance for the year 2022. The company expects revenues of at least €640 million (vs. €625 million previously forecast), An operating profit of around 10.5% (vs > 10%).
Upcoming Dividend • Jun 01Upcoming dividend of €1.00 per shareEligible shareholders must have bought the stock before 08 June 2022. Payment date: 10 June 2022. Trailing yield: 2.8%. Lower than top quartile of French dividend payers (4.9%). Higher than average of industry peers (1.6%).
分析記事 • Apr 28Neurones (EPA:NRO) Will Pay A Smaller Dividend Than Last YearNeurones S.A. ( EPA:NRO ) has announced it will be reducing its dividend payable on the 10th of June to €1.00. However...
Reported Earnings • Apr 27Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €579.9m (up 11% from FY 2020). Net income: €37.7m (up 22% from FY 2020). Profit margin: 6.5% (up from 5.9% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 8.3%, compared to a 12% growth forecast for the industry in France.
Price Target Changed • Apr 27Price target increased to €41.00Up from €37.50, the current price target is an average from 3 analysts. New target price is 17% above last closing price of €35.10. Stock is up 25% over the past year.
Board Change • Apr 27Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Mar 11Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €579.9m (up 11% from FY 2020). Net income: €37.7m (up 22% from FY 2020). Profit margin: 6.5% (up from 5.9% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 8.3%, compared to a 11% growth forecast for the industry in France.
分析記事 • Jan 25Should You Be Adding Neurones (EPA:NRO) To Your Watchlist Today?Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
分析記事 • Jan 06Returns At Neurones (EPA:NRO) Appear To Be Weighed DownIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...
分析記事 • Jul 20Returns On Capital At Neurones (EPA:NRO) Paint A Concerning PictureIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Upcoming Dividend • Jun 02Upcoming dividend of €2.00 per shareEligible shareholders must have bought the stock before 09 June 2021. Payment date: 11 June 2021. Trailing yield: 0.7%. Lower than top quartile of French dividend payers (3.8%). Lower than average of industry peers (1.4%).
Price Target Changed • May 12Price target increased to €32.50Up from €30.00, the current price target is an average from 2 analysts. New target price is 18% above last closing price of €27.60. Stock is up 36% over the past year.
Price Target Changed • May 06Price target increased to €31.00Up from €28.25, the current price target is an average from 2 analysts. New target price is 8.0% above last closing price of €28.70. Stock is up 47% over the past year.
分析記事 • May 06Is Neurones S.A. (EPA:NRO) Trading At A 25% Discount?In this article we are going to estimate the intrinsic value of Neurones S.A. ( EPA:NRO ) by taking the expected future...
Reported Earnings • May 02Full year 2020 earnings released: EPS €1.28 (vs €1.27 in FY 2019)The company reported a mediocre full year result with weaker profit margins, although earnings were flat and revenues improved. Full year 2020 results: Revenue: €524.5m (up 2.8% from FY 2019). Net income: €30.9m (flat on FY 2019). Profit margin: 5.9% (down from 6.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 2% per year.
分析記事 • Mar 24Some Investors May Be Worried About Neurones' (EPA:NRO) Returns On CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
分析記事 • Mar 09Neurones S.A.'s (EPA:NRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?Most readers would already be aware that Neurones' (EPA:NRO) stock increased significantly by 15% over the past three...
Reported Earnings • Mar 06Full year 2020 earnings releasedThe company reported a mediocre full year result with weaker profit margins, although earnings were flat and revenues improved. Full year 2020 results: Revenue: €524.5m (up 2.8% from FY 2019). Net income: €30.9m (flat on FY 2019). Profit margin: 5.9% (down from 6.0% in FY 2019). The decrease in margin was driven by higher expenses.
Analyst Estimate Surprise Post Earnings • Mar 06Revenue beats expectationsRevenue exceeded analyst estimates by 1.2%. Over the next year, revenue is forecast to grow 5.0%, compared to a 33% growth forecast for the IT industry in France.
分析記事 • Feb 16The Neurones (EPA:NRO) Share Price Has Gained 54% And Shareholders Are Hoping For MoreThese days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But you can do a...
Is New 90 Day High Low • Feb 12New 90-day high: €25.70The company is up 9.0% from its price of €23.50 on 13 November 2020. The French market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the IT industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €18.84 per share.
Price Target Changed • Feb 12Price target raised to €29.00Up from €27.00, the current price target is an average from 2 analysts. The new target price is 13% above the current share price of €25.70. As of last close, the stock is up 12% over the past year.
分析記事 • Jan 25Here's Why Neurones's (EPA:NRO) Statutory Earnings Are Arguably Too ConservativeAs a general rule, we think profitable companies are less risky than companies that lose money. However, sometimes...
Price Target Changed • Jan 14Price target raised to €28.25Up from €26.00, the current price target is an average from 2 analysts. The new target price is 21% above the current share price of €23.40. As of last close, the stock is up 14% over the past year.
分析記事 • Jan 11What Percentage Of Neurones S.A. (EPA:NRO) Shares Do Insiders Own?If you want to know who really controls Neurones S.A. ( EPA:NRO ), then you'll have to look at the makeup of its share...
分析記事 • Dec 28Should Neurones S.A. (EPA:NRO) Be Part Of Your Dividend Portfolio?Today we'll take a closer look at Neurones S.A. ( EPA:NRO ) from a dividend investor's perspective. Owning a strong...
Is New 90 Day High Low • Dec 24New 90-day low: €23.00The company is down 3.0% from its price of €23.60 on 24 September 2020. The French market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the IT industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €18.98 per share.
分析記事 • Dec 15Are Neurones S.A. (EPA:NRO) Investors Paying Above The Intrinsic Value?Does the December share price for Neurones S.A. ( EPA:NRO ) reflect what it's really worth? Today, we will estimate the...
分析記事 • Dec 02What We Learned About Neurones' (EPA:NRO) CEO PayThe CEO of Neurones S.A. ( EPA:NRO ) is Luc de Chammard, and this article examines the executive's compensation against...
分析記事 • Nov 17Investors Who Bought Neurones (EPA:NRO) Shares Five Years Ago Are Now Up 39%Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...
Major Estimate Revision • Nov 07Analysts increase EPS estimates to €1.12The 2020 consensus revenue estimate increased from €499.7m to €512.6m. The earnings per share estimate also received an upgrade from €1.00 to €1.12 for the same period. Net income is expected to shrink by 1.2% next year compared to 0.8% growth forecast for the IT industry in France . The consensus price target increased from €26.00 to €27.00. Share price is up 2.1% to €23.90 over the past week.
お知らせ • Oct 04+ 1 more updateNeurones S.A. to Report Fiscal Year 2020 Results on Mar 03, 2021Neurones S.A. announced that they will report fiscal year 2020 results at 3:40 PM, GMT Standard Time on Mar 03, 2021
分析記事 • Jun 30Neurones (EPA:NRO) Is Growing Earnings But Are They A Good Guide?Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...